Nyxoah SA
NYXH•NASDAQ•Healthcare•Medical Instruments & Supplies

About Nyxoah SA

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyEUR - EUR
TypeStock

Contact Information

Websitewww.nyxoah.com
Phone32 1 022 23 55
Address
Rue Edouard Belin 12 Mont-Saint-Guibert, 1435 Belgium

Corporate Identifiers

CIK0001857190
ISINBE0974358906
SIC3841

Leadership Team & Key Executives

Olivier Taelman
Chief Executive Officer and Executive Director
Robert Taub MBA
Co-Founder and Chairman
John Landry
Chief Financial Officer
Bruno Onkelinx
Chief Technical Officer
Pearson Dennis
Investor Relations Associate
An Moonen
General Counsel
Maggie McGowan
Chief Human Resources Officer
Loic Moreau
President of International
Remi Renard
Chief of Staff
Jeyakumar Subbaroyan
Chief Clinical Officer